Cannabis use: Consistency and validity of self-report, on-site urine testing and laboratory testing

Addiction

Volumn 97, Issue SUPPL. 1, 2002, Pages 98-108

  Buchan, Betty J ^a   Dennis, Michael L ^b   Tims, Frank M ^a   Diamond, Guy S ^c  

^a Operation PAR Inc   (United States)

^b CHESTNUT HEALTH SYSTEMS   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adolescent drug use; Self reported drug use; Urine testing

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLITE; MULTICENTER STUDY; PREDICTION; PREVALENCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SELF REPORT; SENSITIVITY AND SPECIFICITY; URINALYSIS; VALIDATION PROCESS;

EID: 0036909104     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.97.s01.1.x     Document Type: Article

References (45)

1. American Psychiatric Association (APA) (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th Edn. Washington, DC: APA.
2. American Society of Addiction Medicine (ASAM) (1996) Patient Placement Criteria for the Treatment of Psychoactive Substance Disorders. 2nd Edn. Chevy Chase, MD: ASAM.
3. Babor, T. F., Brown, J. & Del Boca, F. K. (1990) Validity of self-reports in applied research on addictive behaviors: Fact or fiction? Behavioral Assessment. 12, 5-31.
4. Baselt, R. C. (2000) Disposition of Toxic Drugs and Chemicals in Man, 5th Edn. Foster City, CA: Chemical Toxicology Institute.
5. Bradley, B. P., Gossop, M., Phillips, G. T. & Legarda, J. J. (1987) The development of an opiate withdrawal scale (OWS). British Journal of Addiction, 82, 1139-1142.
6. Clark, S., Turner, J. & Bastiani, R. (1980) EMIT Cannabinoid Assay Clinical Study No. 74. Summary Report. Palo Alto. CA: Syva Co.
7. Cridland, J. S., Rottanburg, D. & Robins, A. H. (1983) Apparent half-life of excretion of cannabinoids in man. Human Toxicology. 2, 641-644.
8. Dackis, C. A., Pottash, A. L., Annitto, W. & Gold, M. S. (1982) Persistence of urinary marijuana levels after supervised abstinence. American Journal of Psychiatry, 139, 1196-1198.
9. Dennis, M. L. (1999) Global Appraisal of Individual Needs (GAIN). Administration Guide for the GAIN and Related Measures. Bloomington, IL: Chestnut Health Systems [online]. Available at: http://www.chestnut.org/li/gain/gadm1299.pdf.
10. Dennis, M. L. (2002) Predicting who needs and gets more treatment after initial assignment to outpatient treatment. In: Mortal, A. R. & Dennis, M. L., eds. Problems of Drug Dependence 2001: Proceedings of the 63rd Annual Scientific Meeting, pp113-115. NIDA Monograph No. 182, NIH Publication No. 02-5097. Bethesda. MD: National Institute on Drug Abuse.
11. Dennis, M., Scott, C., Godley, M. & Funk, R. (1999) Comparisons of Adolescents and Adults by ASAM Using GAIN Data from the Drug Outcome Monitoring Study (DOMS): Preliminary Data Tables. Bloomington, IL: Chestnut Health Systems [online]. Available at: http://www.chestnut.org/LI/Posters/index.html.
12. Dennis, M. L., Titus, J. C., Diamond, G., Donaldson, J., Godley, S. H., Tims, F. M., Webb, C., Kaminer, Y., Babor, T., Roebuck, M., Godley, M. D., Hamilton, N., Liddle, H., Scott, C. & The C. Y. T. Steering committee (2002) The Cannabis Youth Treatment (CYT) experiment: Rationale, study design, and analysis plans. Addiction, 97 (Suppl 1), 16-34.
13. Ellis, G. M., Mann, M. A., Judson, B. A., Schramm, N. T. & Tashchian, A. (1985) Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clinical Pharmacology and Therapeutics, 38, 572-578.
14. 9-THC and other cannabinoids in confiscated marijuana from 1980 to 1997. Journal of Forensic Science, 45, 24-30.
15. Godley, M. D., Godley, S. H., Dennis, M. L., Funk, R. & Passetti, L. (2002) A randomized field trial of an assertive continuing care protocol for adolescents following discharge from residential substance abuse treatment: Preliminary outcomes. Journal of Substance Abuse Treatment, 23, 21-32.
16. Hawks, R. L. (1986) Analytical methodology. In: Hawks, R. L. & Chiang, N. C., eds. Urine Testing for Drug of Abuse. NIDA Research Monograph no. 73, pp. 30-42. Washington, DC: US Government Printing Office.
17. Huang, K. H., Watters, J. K. & Case, P. (1988) Psychological assessment and AIDS research with intravenous drug users. Journal of Psychoactive Drugs, 20, 191-195.
18. Huestis, M. A. & Cone, E. J. (1998) Differentiating new marijuana use from residual drug excretion in occasional marijuana users. Journal of Analytical Toxicology, 22, 445-454.
19. Huestis, M. A., Mitchell, J. M. & Cone, E. J. (1995) Detection times of marijuana metabolites in urine by immunoassay and GC-MS. Journal of Analytical Toxicology, 19, 443-449.
20. 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. Journal of Analytical Toxicology, 13, 218-223.
21. 1-tetrahydrocannabinol in human fat biopsies from marijuana users by gas chromatography-mass spectrometry. Biomedical Chromatography. 3, 35-38.
22. Kanter, S. L. & Hollister, L. E. (1977) Marihuana metabolites in urine of man. Research Communications in Chemistry, Pathology and Pharmacology, 17, 421-431.
23. Kelly, P. & Jones, R. T. (1992) Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. Journal of Analytical Toxicology, 16, 228-235.
24. Leccese, M. & Waldron, H. B. (1994) Assessing adolescent substance use: A critique of current measurement instruments. Journal of Substance Abuse Treatment, 11, 553-563.
25. Lemberger, L. & Rubin, A. (1975) The physiologic disposition of marijuana in man. Life Science, 17, 1637-1642.
26. Losken, A., Maviglia, S. & Friedman, L. S. (1996) Marijuana. In: Friedman L., Fleming, N. F., Roberts, D. H. & Hyman, S. E., eds. Source Book of Substance Abuse and Addiction, pp. 179-187. Maryland: Williams & Wilkins.
27. Magura, S. Goldsmith, D., Casriel, C., Goldstein, R. J. & Lipton. D. S. (1987) The validity of methadone participants' self-reported drug use. International Journal of Addictions. 22, 727-749.
28. Matt, G. E. & Wilson, S. J. (1994) Describing the frequency of marijuana use: Fuzziness and context-dependent interpretation of frequency expressions. Evaluation and Program Planning, 17, 357-369.
29. McNagny, S. E. & Parker, R. M. (1992) High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. Journal of the American Medical Association, 267, 1106-1108.
30. Morral, A. R., McCaffrey, D. & Iguchi, M. Y. (2000) Hardcore drug users claim to be occasional users: Drug use frequency under-reporting. Drug and Alcohol Dependence, 57, 193-202.
31. National Institute on Drug Abuse (1999) Monitoring the Future: Overview of Key Findings 1999. Rockville, MD: Author.
32. Office of Applied Studies (2000d) Treatment Episode Data Set (TEDS) 1993-98: National Admissions to Substance Abuse Treatment Services. DASIS Series S-11. DHHS Publication no. (SMA) 00-3463 Rockville, MD: Substance Abuse and Mental Health Services Adminstration [online]. Available at: http://www.samhsa.gov/statistics.
33. Office of Applied Studies (OAS) (1999) Drug Abuse Warning Network (DAWN). 1999 Report. Rockville, MD: SAMHSA.
34. Owen, P. L. & Nyberg, L. R. (1983) Assessing alcohol and drug problems among adolescents: Current practices. Journal of Drug Education. 13. 249-254.
35. Preston, K. L., Silverman, K., Schuster, C. R. & Cone, E. J. (1997) Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. In: Harrison L. & Hughes, A., eds. The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates. NIDA Research Monograph no. 167, pp. 130-145. Washington, DC: US Government Printing Office.
36. Rush, A. J., Pincus, H. A., First, M. B., Blacker, D., Endicott, J., Keith, S. J., Phillips, K. A., Ryan, N. D., Smith, G. R., Tsuang, M. T., Widiger, T. A. & Zarin, D. A. (2000) Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association.
37. Shen, H., Foss, M., Boles, S., Dennis, M. L., Hser, Y. & Scott, C. (2001) Consistency of self-reported drug use and urinalysis results. Prepared and presented for the 63rd Annual College on Problems of Drug Dependence (CPDD) Conference. June 16-21. Scottsdale, AZ.
38. Shrout, P. E., Spitzer, R. L. & Fleiss, J. L. (1987) Quantification of agreement in psychiatric diagnosis revisited. Archives of General Psychiatry, 44, 172-177.
39. Swatek, R. (1984) Marijuana use: Persistence and urinary elimination. Journal of Substance Abuse Treatment, 1, 265-270.
40. Syva Co. (1982) EMIT D.A.U. and EMIT ST Urine Cannabinoid Assays. Clinical Summary Addendum. Palo Alto, CA: Syva Co.
41. Tims, F., Dennis, M. L., Hamilton, N., Buchan, B., Diamond, G., Funk, R. & Brantley, L. (2002) Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction, 97 (Suppl 1), 46-57.
42. Verebey, K. & Buchan, B. J. (1997) Diagnostic laboratory: Screening for drug abuse. In: Lowinson, J. H., Ruiz, P., Millman, R. B. & Langrod. J. G., eds. Substance Abuse: A Comprehensive Textbook, pp. 369-377. Baltimore, MD: Williams & Wilkins.
43. Wall, M. E., Sadler, B. M., Brine, D., Taylor, H. & Perez-Reyes. M. (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clinical Pharmacology and Therapeutics, 34, 352-363.
44. Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., Williams, M. & Chitwood, D. D. (1994) Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17, 347-355.
45. Winters, K. C. (1990) The need for improved assessment of adolescent substance involvement. Journal of Drug Issues, 20, 487-502.